Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
139.18
-2.42 (-1.71%)
At close: Mar 25, 2025, 4:00 PM
140.38
+1.20 (0.86%)
After-hours: Mar 25, 2025, 4:38 PM EST

Biogen Market Cap

Biogen has a market cap or net worth of $20.37 billion as of March 25, 2025. Its market cap has decreased by -36.11% in one year.

Market Cap
20.37B
Enterprise Value
24.71B
1-Year Change
-36.11%
Ranking
Category
Stock Price
$139.18

Market Cap Chart

Since December 1, 1998, Biogen's market cap has increased from $617.50M to $20.37B, an increase of 3,199.18%. That is a compound annual growth rate of 14.20%.

History

DateMarket Cap% Change
Mar 24, 202520.73B-6.99%
Dec 31, 202422.28B-40.57%
Dec 29, 202337.50B-5.97%
Dec 30, 202239.88B13.15%
Dec 31, 202135.24B-6.47%
Dec 31, 202037.68B-29.63%
Dec 31, 201953.54B-11.69%
Dec 31, 201860.63B-10.00%
Dec 29, 201767.37B9.19%
Dec 30, 201661.70B-9.65%
Dec 31, 201568.29B-14.82%
Dec 31, 201480.16B21.39%
Dec 31, 201366.04B90.69%
Dec 31, 201234.63B29.54%
Dec 30, 201126.73B67.31%
Dec 31, 201015.98B3.27%
Dec 31, 200915.47B11.34%
Dec 31, 200813.90B-16.78%
Dec 31, 200716.70B0.70%
Dec 29, 200616.58B7.90%
Dec 30, 200515.37B-30.83%
Dec 31, 200422.22B288.89%
Dec 31, 20035.71B12.55%
Dec 31, 20025.08B-51.71%
Dec 31, 200110.51B21.91%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 765.04B
UnitedHealth Group 469.66B
Johnson & Johnson 388.08B
AbbVie 356.11B
Novo Nordisk 335.17B
AstraZeneca 227.33B
Merck & Co. 221.91B
Abbott Laboratories 217.87B
Market Cap Rankings